CNS & Neurological Disorders-Drug Targets

Papers
(The median citation count of CNS & Neurological Disorders-Drug Targets is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model54
Scopolamine, a Toxin-Induced Experimental Model, Used for Research in Alzheimer’s Disease48
The Role of Annexin A1 and Formyl Peptide Receptor 2/3 Signaling in Chronic Corticosterone-Induced Depression-Like behaviors and Impairment in Hippocampal-Dependent Memory44
Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder35
When Sick Brain and Hopelessness Meet: Some Aspects of Suicidality in the Neurological Patient34
Benzodiazepines and Sleep Architecture: A Systematic Review30
Role of Calcium Homeostasis in Ischemic Stroke: A Review26
Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol26
MAPK: A Key Player in the Development and Progression of Stroke25
Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment23
Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases23
Arachidonic Acid Derivatives and Neuroinflammation20
Detection, Treatment Planning, and Genetic Predisposition of Bruxism: A Systematic Mapping Process and Network Visualization Technique19
Stingless Bee Honey Reduces Anxiety and Improves Memory of the Metabolic Disease-induced Rats19
Role of Vitamins in Neurodegenerative Diseases: A Review18
ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders17
Role of Brain-Gut-Microbiota Axis in Depression: Emerging Therapeutic Avenues17
Speech as a Biomarker for Depression17
Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Naï ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immun17
Current Strategies and Novel Drug Approaches for Alzheimer Disease17
Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic17
Levodopa Therapy for Parkinson's Disease: History, Current Status and Perspectives17
Modeling Parkinson’s Disease in Zebrafish16
Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal Exposure16
Oxidative Stress in the Pathogenesis of Alzheimer’s Disease and Cerebrovascular Disease with Therapeutic Implications16
BDNF-TrkB and proBDNF-p75NTR/Sortilin Signaling Pathways are Involved in Mitochondria-Mediated Neuronal Apoptosis in Dorsal Root Ganglia after Sciatic Nerve Transection15
The Effects and Regulatory Mechanism of Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi in Promoting Neurogenesis and Improving Memory Impairment Mediated by the BDNF-ERK-CREB Signa15
Markers of Neuroinflammation in the Serum of Prepubertal Children with Fetal Alcohol Spectrum Disorders14
Melatonin and Sleep Disturbances in Alzheimer’s Disease14
Novel Targets Explored in the Treatment of Alcohol Withdrawal Syndrome14
The MMP-2/TIMP-2 System in Alzheimer Disease14
Sepsis-Associated Encephalopathy: Insight into Injury and Pathogenesis13
Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update13
Neurological Associations of SARS-CoV-2 Infection: A Systematic Review13
Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article13
Microglial Cathepsin B and Porphyromonas gingivalis Gingipains as Potential Therapeutic Targets for Sporadic Alzheimer’s Disease12
Neural Basis of Dental Pulp Stem Cells and its Potential Application in Parkinson’s Disease12
Arachidonic Acid Metabolites in Neurologic Disorders12
Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases12
An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis12
Smartphone Addiction among Students and its Harmful Effects on Mental Health, Oxidative Stress, and Neurodegeneration towards Future Modulation of Anti-Addiction Therapies: A Comprehensive Survey base11
Regulatory Role of Chinese Herbal Medicine in Regulated Neuronal Death11
Tumor Treating Fields – Behind and Beyond Inhibiting the Cancer Cell Cycle11
The locus of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms11
A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease10
Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches10
Role of Natural Plant Products Against Alzheimer’s Disease10
Improvement of a Novel Proposal for Antioxidant Treatment Against Brain Damage Occurring in Ischemic Stroke Patients10
Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?10
MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice10
Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Regulate the Brain Tau Hyperphosphorylation at Multiple Sites Induced by Composited Aβ in Rats10
Dietary Nutrients and Prevention of Alzheimer’s Disease10
Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders10
Migraine and Obesity: Is There a Relationship? A Systematic Review and Meta-Analysis of Observational Studies10
Spastin Interacts with CRMP2 to Regulate Neurite Outgrowth by Controlling Microtubule Dynamics through Phosphorylation Modifications9
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review9
Drosophila melanogaster a Versatile Model of Parkinson’s Disease9
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings9
Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease9
Rethinking Catatonia: New Insights from the Autism Spectrum9
The Development of a PBPK Model for Atomoxetine Using Levels in Plasma, Saliva and Brain Extracellular Fluid in Patients with Normal and Deteriorated Kidney Function9
Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments9
Intestinal Barrier Dysfunction Participates in the Pathophysiology of Ischemic Stroke8
Resolution-Associated Molecular Patterns (RAMPs) as Endogenous Regulators of Glia Functions in Neuroinflammatory Disease8
Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier8
Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer’s Disease: A Recent Update8
Dopamine as a Potential Target for Learning and Memory: Contributing to Related Neurological Disorders8
Structural Activity Relationship based Medicinal Perspectives of Pyrimidine Derivatives as Anti-Alzheimer’s Agents: A Comprehensive Review8
Design and Microwave-Assisted Synthesis of Aza-Resveratrol Analogs with Potent Cholinesterase Inhibition8
The Mechanism of Action of Salsolinol in Brain: Implications in Parkinson’s Disease8
Deciphering the Role of Aberrant Protein Post-Translational Modification in the Pathology of Neurodegeneration8
A Pivotal Role of the Nrf2 Signaling Pathway in Spinal Cord Injury: A Prospective Therapeutics Study8
Overview of Therapeutic Drugs and Methods for the Treatment of Parkinson’s Disease8
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy7
Exploring the Various Aspects of Brain-Derived Neurotropic Factor (BDNF) in Diabetes Mellitus7
Management of Impulse Control Disorders with Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease7
Transdermal Drug Delivery Systems and their Potential in Alzheimer’s Disease Management7
Tremor and Rigidity in Patients with Parkinson’s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors7
Oxytocin Effect in Adult Patients with Autism: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials7
Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation7
Elucidations of Molecular Mechanism and Mechanistic Effects of Environmental Toxicants in Neurological Disorders7
Importance of Zebrafish as an Efficient Research Model for the Screening of Novel Therapeutics in Neurological Disorders7
Neuroprotective Role of the B Vitamins in the Modulation of the Central Glutamatergic Neurotransmission7
Nanotechnology: Its Application in Treating Neurodegenerative Diseases7
GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies7
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a 7
Integrated System Pharmacology and In Silico Analysis Elucidating Neuropharmacological Actions of Withania somnifera in the Treatment of Alzheimer’s Disease6
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO6
Anti-Neuropathic Pain Activity of Ageratum conyzoides L due to the Essential Oil Components6
The Role of Statins in the Management of Delirium: Recent Advances6
CGRP and CGRP-Receptor as Targets of Migraine Therapy: Brain Prize-20216
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease6
Role of Forkhead Transcription Factors of the O Class (FoxO) in Development and Progression of Alzheimer’s Disease6
Biomarker Validation of a New Case Definition of Menstrual Cycle-Associated Syndrome (MCAS) Opinion Paper6
Rationalizing the Use of Polyphenol Nano-formulations in the Therapy of Neurodegenerative Diseases6
A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship6
Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders6
Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia6
Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761®) in Patients with Amnestic Mild Cognitive Impairment6
Transdermal Nutraceuticals Delivery System for CNS Disease6
The AMPAR Antagonist Perampanel Regulates Neuronal Necroptosis via Akt/GSK3β Signaling After Acute Traumatic Injury in Cortical Neurons6
Targeting Microglial Polarization to Improve TBI Outcomes6
In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity6
Mechanistic Insight and Possible Mechanism of Seizure in Covid-19: The Nuances and Focal Points6
Nanomedicinal Strategies as Emerging Therapeutic Avenues to Treat and Manage Cerebral Ischemia6
Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction6
Histone Deacetylase Inhibitors Prevented the Development of Morphine Tolerance by Decreasing IL6 Production and Upregulating μ-Opioid Receptors5
Phytotherapeutics against Alzheimer’s Disease: Mechanism, Molecular Targets and Challenges for Drug Development5
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia5
Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease5
The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer’s Disease5
Myasthenia Gravis and Vitamin D Serum Levels: A Systematic Review and Meta-analysis5
Age and Dose-Dependent Effects of Alpha-Lipoic Acid on Human Microtubule- Associated Protein Tau-Induced Endoplasmic Reticulum Unfolded Protein Response: Implications for Alzheimer’s Disease5
Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis5
Madecassic Acid Reduces Fast Transient Potassium Channels and Promotes Neurite Elongation in Hippocampal CA1 Neurons5
The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?5
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health5
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets5
Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells5
In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models5
Cardiac Biomarkers in Stroke, Alzheimer’s Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations5
Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches5
Radiotherapy and Its Impact on the Nervous System of Cancer Survivors5
Dopaminergic Signaling as a Plausible Modulator of Astrocytic Toll-Like Receptor 4: A Crosstalk between Neuroinflammation and Cognition5
Non-hepatic Hyperammonemia: A Potential Therapeutic Target for Sepsis-associated Encephalopathy5
Melatonin Alleviates Pyroptosis of Retinal Neurons Following Acute Intraocular Hypertension5
Immunotherapies for Parkinson’s Disease: Progression of Clinical Development5
Rolipram Rescues Memory Consolidation Deficits Caused by Sleep Deprivation: Implication of the cAMP/PKA and cAMP/Epac Pathways5
Pharmacotherapeutic Potential of Garlic in Age-Related Neurological Disorders5
Fibrosis and Regulation of Nerve Regeneration in the Peripheral and Central Nervous Systems5
Neuronal Excitability in Epileptogenic Zones Regulated by the Wnt/ Β-Catenin Pathway5
Neurorestoratology: New Advances in Clinical Therapy5
Natural Products as Bioactive Agents in the Prevention of Dementia5
Comparison of the Sedative Effect of Ketamine, Magnesium Sulfate, and Propofol in Patients Undergoing Upper Gastrointestinal Endoscopy: Double-Blinded Randomized Clinical Trial4
1,3,5-Pyrazoline Derivatives in CNS Disorders: Synthesis, Biological Evaluation and Structural Insights through Molecular Docking4
A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease4
Minocycline Inhibits mTOR Signaling Activation and Alleviates Behavioral Deficits in the Wistar Rats with Acute Ischemia stroke4
Neuroprotective Efficacy of Edaravone against Arsenic-Induced Behavioral and Neurochemical Deficits in Rats: Amelioration of Cholinergic and Mitochondrial Functions4
Herbal Approaches in the Management of Mental Depression4
A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions4
Neuroprotective effect of 3,3′-diindolylmethane and ɑ-naphthoflavone, aryl hydrocarbon receptor modulators in an experimental model of ischemic stroke4
Liver-Brain Axis in Sporadic Alzheimer’s Disease: Role of Ten Signature Genes in a Mouse Model4
Drosophila: A Model to Study the Pathogenesis of Parkinson’s Disease4
Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology4
Inter/Transgenerational Effects of Drugs of Abuse: A Scoping Review4
Evidence on the New Drug Lumateperone (ITI-007) for Psychiatric and Neurological Disorders4
Selective Inhibition of Soluble TNF using XPro1595 Improves Hippocampal Pathology to Promote Improved Neurological Recovery Following Traumatic Brain Injury in Mice4
COVID-19 Outbreak: Neurological Manifestations Beyond Cough and Fever4
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis4
Yishen Huazhuo Decoction Induces Autophagy to Promote the Clearance of Aβ1-42 in SAMP8 Mice: Mechanism Research of a Traditional Chinese Formula Against Alzheimer’s Disease4
Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease4
Nanotechnological Advances in the Treatment of Epilepsy4
Targeting Brain Cancer Cells by Nanorobot, a Promising Nanovehicle: New Challenges and Future Perspectives4
Metabolic Adjustments by LncRNAs in Peripheral Neutrophils Partly Account for the Complete Compensation of Asymptomatic MMD Patients4
Epigenetic Basis of Psychiatric Disorders: A Narrative Review4
Impact of Cannabis-Based Medicine on Alzheimer’s Disease by Focusing on the Amyloid β-Modifications: A Systematic Study4
The Protective Effect of Vitexin Compound B-1 on Rat Cerebral I/R Injury through a Mechanism Involving Modulation of miR-92b/NOX4 Pathway4
An Overview of Acute Flaccid Myelitis4
Intriguing Role of Gut-Brain Axis on Cognition with an Emphasis on Interaction with Papez Circuit4
High-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Accelerates onset Time of Beneficial Treating Effects and Improves Clinical Symptoms of Depression4
Importance of Exploring N-Methyl-D-Aspartate (NMDA) as a Future Perspective Target in Depression4
Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review4
Modulation of Huntington’s Disease in Drosophila4
A Review on Pathophysiological Aspects of Sleep Deprivation4
Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps4
Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase4
COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?4
Ethanolamine: A Potential Promoiety with Additional Effects on the Brain4
Thoughts of Death, Depression and Guilt in a Healthcare Worker Who Infected Her Husband with SARS-CoV-2: A Case Report3
Zederone Improves the Fecal Microbial Profile in Dementia Induced Rat Model: A First Report3
Dipsacoside B Exerts a Beneficial Effect on Brain Injury in the Ischemic Stroke Rat through Inhibition of Mitochondrial E3 Ubiquitin Ligase 13
CSF Levels of the Endocannabinoid Anandamide are Reduced in Patients with Untreated Narcolepsy Type 1: A Pilot Study3
A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease3
Treatment of Catatonia with Asenapine in a Patient with Schizotypal Personality Disorder, Psychotic Depression and Septic Shock from SARSCoV- 2 - A Case Report3
Magic Shotgun Nature with Scattergun Approach of Curcumin Repurposing in Obsessive-compulsive Disorder: A Novel Metaphysician of Drug Discovery3
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 3
Effective Connectivity Between the Orbitofrontal Cortex and the Precuneus Differentiates Major Psychiatric Disorders: Results from a Transdiagnostic Spectral DCM Study3
Perspective on Cav-1 for its Potential as Newer Therapeutics for Parkinson’s Disease3
Apoptosis in the Dentate Nucleus Following Kindling-induced Seizures in Rats3
The Protective Effects of Pioglitazone Against Cognitive Impairment Caused by L-methionine Administration in a Rat Model3
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety3
Impact of COVID-19 on Anxiety and Depression - Biopsychosocial Factors3
Anti-neuropathic Pain Mechanistic Study on A. conyzoides Essential Oil, Precocene II, Caryophyllene, or Longifolene as Single Agents and in Combination with Pregabalin3
Conifer Essential Oils Reversed Amyloid Beta1-42 Action by Modulating BDNF and ARC Expression in The Rat Hippocampus3
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease3
Neuroregenerative Activity of the Dipeptide Mimetic of Brain-derived Neurotrophic Factor GSB-106 Under Experimental Ischemic Stroke3
Topiramate Decelerates Bicarbonate-Driven Acid-Elimination of Human Neocortical Neurons: Strategic Significance for its Antiepileptic, Antimigraine and Neuroprotective Properties3
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease3
Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer’s Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer’s Disease3
A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis3
Therapeutic Effects of Thymoquinone on Alzheimer’s Disease through Modulating Amyloid-beta Neurotoxicity and Neuro-inflammatory Cytokine Levels3
Psychiatric Manifestations of COVID-19: A Literature Review3
Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer’s Disease3
In Vivo Antidepressant Efficacy of 3-Substituted Thietane-1,1-dioxide Derivative - A Preliminary Study for Novel Anti-Depression Therapy in Neurological Disorders3
Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer’s Disease3
Mini-Review on SARS-CoV-2 Infection and Neurological Manifestations: A Perspective3
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease3
Evaluation of Associated Genes with Traumatic Pain: A Systematic Review3
Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation3
Berberine Ameliorates Cognitive Impairment by Regulating Microglial Polarization and Increasing Expression of Anti-inflammatory Factors following Permanent Bilateral Common Carotid Artery Occlusion in3
Brain Damage in the Preterm Infant: Clinical Aspects and Recent Progress in the Prevention and Treatment3
Eugenol Elicits Prolongevity by Increasing Resistance to Oxidative Stress in C. elegans3
Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease2
The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer’s Disease2
Mechanisms Involved in Neuroprotective Effects of Transcranial Magnetic Stimulation2
A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches2
Role of Lipocalin-2 in N1/N2 Neutrophil Polarization After Stroke2
Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage2
Functional Neuroproteomics: An Imperative Approach for Unravelling Protein Implicated Complexities of Brain2
Modifiable Risk Factors Associated with Alzheimer’s Disease with Special Reference to Sleep Disturbance2
Epigenetic Modifications by Estrogen and Androgen in Alzheimer’s Disease2
Deciphering the Influence of Cigarette Smoke Carcinogens on CNS Associated Biomolecules: A Computational Synergistic Approach2
The Effects and Mechanism of Scutellaria baicalensis Georgi Stems and Leaves Flavonoids on Myelin Sheath Degeneration Induced by Composite Aβ in Rats2
Mini Review on Cariprazine: A Promising Antipsychotic Agent2
Brain-Derived Neurotrophic Factor – The Protective Agent Against Neurological Disorders2
Reciprocal Interaction of Pain and Brain: Plasticity-induced Pain, Pain-induced Plasticity, and Therapeutic Targets2
New Psychometric Strategies for the Evaluation of Affective, Cognitive, and Psychosocial Functioning in Unipolar versus Bipolar Depression: Impact of Drug Treatment2
Hematological Consequences of Valproic Acid in Pediatric Patients: A Systematic Review with a Mechanistic Approach2
SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia?2
Exploring the Hypothesis of a Schizophrenia and Bipolar Disorder Continuum: Biological, Genetic and Pharmacologic Data2
Arachidonic Acid Mediators and their Role in Neurological Disease2
Dioclea Altissima Seed Lectin (DAL) Prevents Anxiety-like Behavioral Responses in Adult Zebrafish (Danio Rerio): Involvement of GABAergic and 5-HT Systems2
Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam2
Bumetanide, a Diuretic That Can Help Children with Autism Spectrum Disorder2
Plants and their Bioactive Compounds as a Possible Treatment for Traumatic Brain Injury-Induced Multi-Organ Dysfunction Syndrome2
Immunotherapeutics for AD: A Work in Progress2
Preface2
The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update2
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals2
A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders2
Interactions between Ketamine and Magnesium for the Treatment of Pain: Current State of the Art2
A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives2
An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease2
The Outcomes of Small-Molecule Kinase Inhibitors and the Role of ROCK2 as a Molecular Target for the Treatment of Alzheimer's Disease2
Cutaneomeningospinal Angiomatosis (Cobb Syndrome) in a Young Patient2
Lorcaserin: Worthy of Further Insights? Results from Recent Research2
Sleep Disorders Research From 1945 to 2020: A Bibliometric Analysis2
Neural Receptors Associated with Depression: A Systematic Review of the Past 10 Years2
Does Human Alpha-Synuclein Behave Like Prions?2
MicroRNA-Targeted Signaling Pathways in the Autism Spectrum Disorder: Implications for Early Detection and Targeted Therapy2
Immunotherapy for Pediatric Gliomas: CAR-T Cells Against B7H3: A Review of the Literature2
L-Ala-L-Gln Suppresses Hypoxic Phenotype and Fibrogenic Activity of Rat Perineurial Fibroblasts2
Acute Phenobarbital Poisoning for the Management of Seizures in Newborns and Children; A Systematic Literature Review2
Elucidating the Role of Trauma and Significant Life Stress in the Disease of Addiction may Provide New Targets for Medication Development2
Impact of Dimethylfumarate on Sleep in Multiple Sclerosis Patients: An Actigraphic Study2
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer’s Disease Pathogenesis2
Comparing the Efficacy and Safety of Dexmedetomidine/Ketamine with Propofol/Fentanyl for Sedation in Colonoscopy Patients: A Doubleblinded Randomized Clinical Trial2
The Combination of rTMS and Pharmacotherapy on In Vitro Models: A Mini-Review2
Foresee Novel Targets for Alzheimer’s Disease by Investigating Repurposed Drugs2
Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression2
0.037977933883667